GlassScriptPhysician profile
Swati Gupta
NPI 1386035772
$2,960.52
in general payments reported to CMS, 2019-2025
32 companies · $580 in 2025
The $580 reported for 2025 was more than what 76% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $597 · 2020: $562 · 2021: $137 · 2022: $295 · 2023: $433 · 2024: $357 · 2025: $580.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,370.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,369.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $363.90 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Abbott Laboratories | $271.22 | 2022-2025 | Freestyle Libre 2, Freestyle Libre 3 |
| Pfizer INC. | $264.63 | 2019-2025 | |
| Glaxosmithkline, LLC. | $245.96 | 2019-2025 | Shingrix, Arexvy |
| Astrazeneca Pharmaceuticals LP | $225.06 | 2019-2025 | Farxiga |
| Lilly USA, LLC | $182.16 | 2019-2023 | Mounjaro, Jardiance, Trulicity |
| Sanofi-Aventis U.S. LLC | $163.35 | 2019-2021 | |
| Dexcom, INC. | $124.83 | 2022-2025 | Dexcom G6 Transmitter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $109.86 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $106.96 | 2019-2025 | Capvaxive, Gardasil 9 |
| Nusmile, LTD. | $105.02 | 2024 | Zarc Files |
| Exact Sciences Corporation | $88.79 | 2023-2025 | Cologuard Collection Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $87.70 | 2019-2023 | Xifaxan, Trulance |
| Amgen INC. | $77.16 | 2019-2025 | Repatha, Otezla, Otezla |
| Genentech USA, INC. | $72.33 | 2019 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corcept Therapeutics | $62.49 | 2025 | Korlym |
| Cvrx, INC. | $48.85 | 2024 | Barostim Neo System |
| Amarin Pharma, INC. | $42.75 | 2020 | |
| Janssen Pharmaceuticals, INC | $40.50 | 2024-2025 | Spravato |
| E.R. Squibb & Sons, L.L.C. | $38.37 | 2025 | Camzyos |
| Bayer Healthcare Pharmaceuticals INC. | $38.23 | 2023-2025 | |
| Bardy Diagnostics, INC. | $31.12 | 2020 | |
| Sanofi Pasteur INC. | $29.27 | 2019 | |
| Optos, INC. | $20.14 | 2020 | |
| Baxter Healthcare | $18.84 | 2025 | Hillrom - Cardiac Ambulatory Monitor |
| Abbvie INC. | $17.99 | 2024 | |
| Depuy Synthes Sales INC. | $15.85 | 2025 | Monovisc, Orthovisc |
| Lifescan, INC. | $14.88 | 2023 | |
| Modernatx, INC. | $13.85 | 2025 | Mresvia |
| Averitas Pharma INC. | $13.47 | 2024 | Qutenza |
| Kowa Pharmaceuticals America, INC. | $12.80 | 2020 | |
| Hikma Pharmaceuticals USA | $12.19 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Swati Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.